한국과 중국의 코로나-19 진료지침의 한약에 대한 비교분석 및 고찰
Analysis of Herbal Medicine in the Clinical Guidelines of Korea and China for COVID-19
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
COVID-19 is an acute infectious disease caused by SARS-CoV-2 that has infected more than 700 million people around the world and left many deaths. In Korea and China, Korean medicine and Traditional Chinese Medicine were used to treat COVID-19, and the key element between them was herbal medicine. Clinical guidelines for herbal medicine have been published in Korea and China. In this review, the Korean and Chinese guidelines were compared and analyzed. This review was based on the latest revised clinical guidelines. The Korean guidelines covered all three guidelines published by The Association of Korean Medicine and The KM Professor Council of Internal Medicine of the Respiratory System. The Chinese guideline was published by the China National Health Commission. Based on research trends, a comprehensive comparison was made of the suggested prescriptions for each severity of COVID-19. It is expected that this review will be used as a reference for the treatment of COVID-19 or new infectious diseases in the future.
Abstract
COVID-19 is an acute infectious disease caused by SARS-CoV-2 that has infected more than 700 million people around the world and left many deaths. In Korea and China, Korean medicine and Traditional Chinese Medicine were used to treat COVID-19, and the key element between them was herbal medicine. Clinical guidelines for herbal medicine have been published in Korea and China. In this review, the Korean and Chinese guidelines were compared and analyzed. This review was based on the latest revised clinical guidelines. The Korean guidelines covered all three guidelines published by The Association of Korean Medicine and The KM Professor Council of Internal Medicine of the Respiratory System. The Chinese guideline was published by the China National Health Commission. Based on research trends, a comprehensive comparison was made of the suggested prescriptions for each severity of COVID-19. It is expected that this review will be used as a reference for the treatment of COVID-19 or new infectious diseases in the future.
참고문헌 (31)
- Wang C, "A novel coronavirus outbreak of global health concern", The lancet, 395(10223), pp.470~473 (2020)
- "Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic" (2023)[URL]
- "WHO Coronavirus (COVID-19) Dashboard" (2023)[URL]
- "질병관리청 코로나바이러스감염증-19" (2023)[URL]
- National Evidence-based Healthcare Collaborating Agency, "코로나19 환자 치료를 위한 임상진료지침", National Evidence-based Healthcare Collaborating Agency, Korean Academy of Medical Sciences, ~ (2022)
- Wang R, "Clinical observation of Qingfeipaidu Decoction in the treatment of COVID-19", Pharmacology and Clinics of Chinese Materia Medica, 36(1), pp.13~18 (2020)
- Hu K, "Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019 : A multicenter, prospective, randomized controlled trial", Phytomedicine, 85, pp.153242~ (2021)
- Lin TPH, "Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong", Front Med(Lausanne), 9, pp.948149~ (2022)
- Xiao-Bin Zhu, "Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review", Integrative Medicine Research, 10(4), pp.1~8 (2021), 한국한의학연구원[DOI]
- "新型冠状病毒感染诊疗方案(试行第十版). (10)" (2023)[URL]
- The KM Professor Council of Internal Medicine of the Respiratory System, "코로나바이러스감염증-19 한의진료지침. 2.1판", The KM Professor Council of Internal Medicine of the Respiratory System, ~ (2020)
- The Association of Korean Medicine, "코로나19한의진료지침 권고안. 2판", The Association of Korean Medicine, ~ (2020)
- Lin Ang, "Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines", Integrative Medicine Research, 9(2), pp.1~14 (2020), 한국한의학연구원[DOI]
- 김동수, "Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis", Integrative Medicine Research, 9(3), pp.1~5 (2020), 한국한의학연구원[DOI]
- 권승원, "Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review", Integrative Medicine Research, 9(3), pp.1~7 (2020), 한국한의학연구원[DOI]
- 강보형, "COVID-19에 대한 청폐배독탕의 연구 동향 분석", 대한한방내과학회지, 41(3), pp.424~433 (2020), 대한한방내과학회[DOI]
- Zhang L, "Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19 : A systematic review and meta-analysis", Phytomedicine, 102, pp.154166~ (2022)
- Wu Y, "Effect and Mechanism of Qingfei Paidu Decoction in the Management of Pulmonary Fibrosis and COVID-19", Am J Chin Med, 50(1), pp.33~51 (2022)
- Li J, "Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology", Int J Med Sci, 19(2), pp.213~224 (2022)
- Wu J, "Application of Jiawei Maxing Shigan Tang in the treatment of COVID-19: An observational study", Front Med (Lausanne), 9, pp.1028171~ (2022)
- Si X, "Efficacy and safety of Jinhua Qinggan granules in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis", Medicine(Baltimore), 102(15), pp.e33545~ (2023)
- Sun XH, "Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19 : A Systematic Review and Meta-Analysis", Chin J Integr Med, 28(7), pp.650~660 (2022)
- Wu-zhong Xiong, "Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial", Integrative Medicine Research, 9(3), pp.1~4 (2020), 한국한의학연구원[DOI]
- Liu J, "Combination of Hua Shi Bai Du granule(Q-14)and standard care in the treatment of patients with coronavirus disease 2019(COVID-19) : A single-center, open-label, randomized controlled trial", Phytomedicine, 91, pp.153671~ (2021)
- Liu S, "Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis : The EXIT-SEP Randomized Clinical Trial", JAMA Intern Med, pp.e230780~ (2023)
- Li C, "Efficacy and safety of Xuebijing injection(a Chinese patent)for sepsis : A meta-analysis of randomized controlled trials", J Ethnopharmacol, 224, pp.512~521 (2018)
- Crook H, "Long covid-mechanisms, risk factors, and management", bmj, 374, pp.n1648~ (2021)
- Li L, "Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge : A Prospective Cohort and Nested Case-Control Study", Chin J Integr Med, 27(4), pp.245~251 (2021)
- Liu X, "Chinese herbs combined with Western medicine for severe acute respiratory syndrome(SARS)", Cochrane Database Syst Rev, 10(10), pp.Cd004882~ (2012)
- 김상현, "COVID-19의 中醫 진료방안에 반영된 문헌 근거에 대한 고찰", 대한한의학원전학회지, 35(4), pp.115~125 (2022), 대한한의학원전학회
- Zhang L, "Becoming a Faithful Defender : Traditional Chinese Medicine against Coronavirus Disease 2019(COVID-19)", Am J Chin Med, 48(4), pp.763~777 (2020)
